Komori
Presentation materials for financial results3649FINDEX Inc.Information and Communications, Services and Others

Financial Results Presentation for the Second Quarter of the Fiscal Year Ending December 2026

In the first half of FY2026 December, revenue increased 0.6% year on year, while operating profit declined 7.0% and net income declined 18.2%. The Medical and Health Tech businesses reported higher revenue and profit or reduced losses, but the decline following the completion of large public-sector projects and higher costs associated with business expansion weighed on profit.

Worth reading
87Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Contents of this document

Presentation materials for financial resultsSecond quarter of the fiscal year ending December 202613 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥3,145 million+0.6%
Operating profit¥888 million-7.0%
Ordinary income¥922 million-6.4%
Net income¥560 million-18.2%
Selling, general and administrative expenses¥1,180 million
Operating profit margin28.2% (year-on-year change in percentage points: Not disclosed)
Results for the three months of the current quarter
Net Sales
¥1,693 million
Operating profit
¥85 million
Orders received
¥772 million
Order backlog
¥1,799 million
Full-year earnings forecast
Net Sales
¥6,209 million
Operating profit
¥1,829 million
Ordinary income
¥1,889 million
Profit attributable to owners of the parent
¥1,302 million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales50.7% (consolidated total)
Operating profit48.6% (consolidated total)
Ordinary income48.8% (consolidated total)
Profit attributable to owners of the parent43.1% (consolidated total)
Medical business revenue53.3%
Public business revenue41.3%
Healthtech business revenue19.1%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Overall progress is in line with plan. The Medical Business is progressing smoothly against plan. The Public Business lagged, with first-half progress at 41.3% of the full-year plan.
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Operating profit
Revenue factors¥19 million
Gross margin factors¥13 million
Selling, general and administrative expense factor¥-99 million
Operating profit by segment
Healthcare business¥9 million
Public-sector business¥-97 million
Healthtech business¥21 million
New initiatives
  • Preparing to open a new base for the medical data platform business in Tokyo
  • Preparing for the full-scale launch of the certified business under the Next-Generation Medical Infrastructure Act
  • Promoting consulting and contract development in the medical data platform business
  • Renewal of the ERP system
  • Investment in security
  • Preparing for overseas lot shipments of GAP
  • Development project for goggle-type medical devices
Key KPIsA metric the company considers important as a management benchmark.
  • Adoption rate of medical systems at university hospitals in Japan (main hospitals)80 %
  • Number of facilities using medical systems2,269 Facility
  • Total number of public-sector system customers80 Facility
  • Total DocuMaker Office users49,848 people
  • Share of recurring revenue in the Medical segment31.9 %
    Year on year against the same period last year+2.1%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Average number of packages per facility
Large hospitals4.78 Package
Medium-sized hospitals3.11 Package
Small hospitals2.37 Package
Segment results
Healthcare business
Net Sales
¥2,908 million
Revenue_yoy_pct1.8
Operating profit
¥945 million
Operating profit_yoy_pct1
Public-sector business
Net Sales
¥173 million
Revenue_yoy_pct-29.1
Operating profit
¥27 million
Operating profit_yoy_pct-77.6
Healthtech business
Net Sales
¥65 million
Revenue_yoy_pct150.2
Operating profit
¥-85 million
Operating profit_yoy_pctNarrowing operating loss
Medium-term management plan targets
Net Sales
¥8,070 million
Target fiscal year2030
Operating profit
¥3,220 million
Target fiscal year2030
EPS
¥96.3
Target fiscal year2030
Financial targets
ROEMaintain and improve (quantitative target: Not disclosed)
DOELower limit: 8.5%
Market Size / Share
Domestic market size for document management systems
740 Hundreds of millions of yen
SAM for document management systems
400 Hundreds of millions of yen
SOM for document management systems
55 Hundreds of millions of yen
Global market size for visual field analyzers
500 Hundreds of millions of yen
Domestic market size for visual field analyzers
21 Hundreds of millions of yen
Domestic medical systems market size
5,700 Hundreds of millions of yen
Adoption rate at university hospitals in Japan (main hospitals)
80 %
Orders received and order backlog
Orders received
¥772 million
Order backlog
¥1,799 million
Number of employees
Up 14 year on year (total headcount at period-end: Not disclosed)
Annual Dividend
Annual dividend per share¥27
Interim¥13
End of period¥14
Payout ratio
50 %
DOELower limit: 8.5%
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period CoveredSecond quarter of the fiscal year ending December 2026
Net Sales¥3,145 million (YoY +0.6%)
Operating profit¥888 million (YoY -7.0%)
Ordinary income¥922 million (YoY -6.4%)
Net income¥560 million (YoY -18.2%)
Operating profit margin28.2% (year-on-year change in percentage points: Not disclosed)
Selling, general and administrative expenses¥1,180 million
Results for the three months of the current quarterNet Sales ¥1,693 million / Operating profit ¥85 million / Orders received ¥772 million / Order backlog ¥1,799 million
Full-year earnings forecastNet Sales ¥6,209 million / Operating profit ¥1,829 million / Ordinary income ¥1,889 million / Profit attributable to owners of the parent ¥1,302 million
Progress against full-year forecastNet Sales 50.7% (consolidated total) / Operating profit 48.6% (consolidated total) / Ordinary income 48.8% (consolidated total) / Profit attributable to owners of the parent 43.1% (consolidated total) / Medical business revenue 53.3% / Public business revenue 41.3% / Healthtech business revenue 19.1%
Self-assessment against the planOverall progress is in line with plan. The Medical Business is progressing smoothly against plan. The Public Business lagged, with first-half progress at 41.3% of the full-year plan.
Segment resultsHealthcare business Net Sales ¥2,908 million / Revenue_yoy_pct 1.8 / Operating profit ¥945 million / Operating profit_yoy_pct 1 / Public-sector business Net Sales ¥173 million / Revenue_yoy_pct -29.1 / Operating profit ¥27 million / Operating profit_yoy_pct -77.6 / Healthtech business Net Sales ¥65 million / Revenue_yoy_pct 150.2 / Operating profit ¥-85 million / Operating profit_yoy_pct Narrowing operating loss
Breakdown of Factors Affecting the ChangeOperating profit Revenue factors ¥19 million / Gross margin factors ¥13 million / Selling, general and administrative expense factor ¥-99 million / Operating profit by segment Healthcare business ¥9 million / Public-sector business ¥-97 million / Healthtech business ¥21 million
Key KPIsIndicator name Adoption rate of medical systems at university hospitals in Japan (main hospitals) / Value 80 % / Year on year against the same period last year Not disclosed, Indicator name Number of facilities using medical systems / Value 2,269 Facility / Year on year against the same period last year Not disclosed, Indicator name Total number of public-sector system customers / Value 80 Facility / Year on year against the same period last year Not disclosed, Indicator name Total DocuMaker Office users / Value 49,848 people / Year on year against the same period last year Not disclosed, Indicator name Share of recurring revenue in the Medical segment / Value 31.9 % / Year on year against the same period last year 2.1 %
Unit price and quantity metricsAverage number of packages per facility Large hospitals 4.78 Package / Medium-sized hospitals 3.11 Package / Small hospitals 2.37 Package
Number of employeesUp 14 year on year (total headcount at period-end: Not disclosed)
Medium-term management plan targetsNet Sales ¥8,070 million / Operating profit ¥3,220 million / EPS ¥96.3
Financial targetsROE Maintain and improve (quantitative target: Not disclosed) / DOE Lower limit: 8.5%
Annual DividendAnnual dividend per share ¥27 / Interim ¥13 / End of period ¥14
Payout ratio50 %
Orders received and order backlogOrders received ¥772 million / Order backlog ¥1,799 million
Market Size / ShareDomestic market size for document management systems 740 Hundreds of millions of yen / SAM for document management systems 400 Hundreds of millions of yen / SOM for document management systems 55 Hundreds of millions of yen / Global market size for visual field analyzers 500 Hundreds of millions of yen / Domestic market size for visual field analyzers 21 Hundreds of millions of yen / Domestic medical systems market size 5,700 Hundreds of millions of yen / Adoption rate at university hospitals in Japan (main hospitals) 80 %
New initiativesPreparing to open a new base for the medical data platform business in Tokyo, Preparing for the full-scale launch of the certified business under the Next-Generation Medical Infrastructure Act, Promoting consulting and contract development in the medical data platform business, Renewal of the ERP system, Investment in security, Preparing for overseas lot shipments of GAP, Development project for goggle-type medical devices
Items this document does not state (7)
Gross Profit MarginNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookAcquisition of treasury sharesCapital expendituresKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue in the Public Business declined following the completion of large projects in the previous fiscal year, while costs, primarily personnel expenses, increased. Across the group, expenses increased due to the ERP system renewal, security investments and the recruitment of new front-office personnel. In addition, the interim net income attributable to owners of the parent was affected by the recognition of approximately ¥100 million in valuation losses on shares of investee companies.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Presentation for the Second Quarter of the Fiscal Year Ending December 2026 | FINDEX Inc. (3649) timely disclosure | Komori